Livzon Pharma Announces RMB 12.39 Cash Dividend per 10 Shares for Q3 2026, Payment Slated for 23 December 2026

Bulletin Express
10/23

Livzon Pharmaceutical Group Inc. (Livzon Pharma) has declared an ordinary third-quarter cash dividend of RMB 12.39 per 10 shares for the reporting period ended 30 September 2026.

Shareholder approval is scheduled for 12 November 2026. The shares will trade ex-dividend on 25 November 2026, with the record date set for 26 November 2026. Share transfers must be lodged with Tricor Investor Services Limited by 16:30 on 26 November 2026.

Dividend cheques will be dispatched on or before 23 December 2026. Industrial and Commercial Bank of China (Asia) Limited will act as the Hong Kong paying agent. The payment currency for H-shareholders and the applicable exchange rate will be announced closer to the distribution date.

Withholding tax will be applied at 10% for non-resident enterprise shareholders and 20% for resident individual shareholders registered within the PRC.

The company’s board consists of Executive Directors Liu Daping (Chairman and President) and Tang Yanggang (Vice Chairman); Non-Executive Directors Lin Nanqi and Qiu Qingfeng; Employee Representative Director Ran Yongmei; and Independent Non-Executive Directors Luo Huiyuan, Cui Lijie, Wang Zhiyao and Kang Li.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10